Artificial intelligence to unlock real‐world evidence in clinical oncology: A primer on recent advances
Authors:
Open Access
- 20 June 2024
- journal article
- review article
- Published by Wiley in Cancer Medicine
- Vol. 13 (12) , e7253
Abstract
Purpose: Real world evidence is crucial to understanding the diffusion of new oncologic therapies, monitoring cancer outcomes, and detecting unexpected toxicities. In practice, real world evidence is challenging to collect rapidly and comprehensively, often requiring expensive and time‐consuming manual case‐finding and annotation of clinical text. In this Review, we summarise recent developments in the use of artificial intelligence to collect and analyze real world evidence in oncology. Methods: We performed a narrative review of the major current trends and recent literature in artificial intelligence applications in oncology. Results: Artificial intelligence (AI) approaches are increasingly used to efficiently phenotype patients and tumors at large scale. These tools also may provide novel biological insights and improve risk prediction through multimodal integration of radiographic, pathological, and genomic datasets. Custom language processing pipelines and large language models hold great promise for clinical prediction and phenotyping. Conclusions: Despite rapid advances, continued progress in computation, generalizability, interpretability, and reliability as well as prospective validation are needed to integrate AI approaches into routine clinical care and real‐time monitoring of novel therapies.Keywords
Funding Information
- LUNGevity Foundation (2021‐07)
- Melanoma Research Alliance (689853)
- U.S. Department of Veterans Affairs (MVP064)
- U.S. Department of Veterans Affairs (BX005267)
- U.S. Department of Veterans Affairs (150CU000182)
- U.S. Department of Veterans Affairs (VA 150CU000182)
This publication has 95 references indexed in Scilit:
- Dermatologist-level classification of skin cancer with deep neural networksNature, 2017
- Natural Language Processing in OncologyJAMA Oncology, 2016
- Improved Method to Stratify Elderly Patients With Cancer at Risk for Competing EventsJournal of Clinical Oncology, 2016
- Portable automatic text classification for adverse drug reaction detection via multi-corpus trainingJournal of Biomedical Informatics, 2015
- Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-upThe Lancet, 2014
- Information Extraction for Tracking Liver Cancer Patients' Statuses: From Mixture of Clinical Narrative Report TypesTelemedicine and e-Health, 2013
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- Influence of Publication of US and European Prostate Cancer Screening Trials on PSA Testing PracticesJNCI: Journal of the National Cancer Institute, 2011
- Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study1☆Gastroenterology, 2004
- Selection bias in clinical trials.Journal of Clinical Oncology, 1985